NCT01134952View on ClinicalTrials.gov

Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Hepatitis C
Interventions
DRUG

Mycophenolate to sirolimus switch

Sirolimus given for 3 months instead of mycophenolate at a starting dose equivalent of 1 mg sirolimus equal to 1000 mg of mycophenolate.

Trial Locations (1)

N6A5A5

London Health Sciences Centre, London

Sponsors
All Listed Sponsors
lead

London Health Sciences Centre

OTHER